can you take glp-1 without a gallbladder receptor agonists and disease risk: insights into molecular mechanisms and clinical implications GLP-1 Gallbladder Risk: What Clinicians

The need for extensive work in developing a robust safety profile for this peptide cannot be overstated

Y., Kim, E., Park, S

doi: 10.1111/1471-0528.16972 386 SobelJ

Some patients benefit from combined approachesbehavioral coaching plus medicationwhile others achieve goals through medication alone, or through structured behavioral programs without pharmacotherapy

To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth